A new video game is letting players find out what it's like to be the CEO of a company beset by outrage over high drug prices.
The satirical indie "EpiPen Tycoon" browser game lets you play as Mylan CEO Heather Bresch, who has been criticized by the public and lawmakers for raising the price of the allergy drug EpiPen by 400 percent since 2007.
"Your shareholders want results. Your customers want to not die of anaphylactic shock," the game's opening screen reads. "It's up to you to jack the price as high as you can."
To win the game, you have to create a happy medium between outrage from investors and the public. If you raise the price of EpiPen too much, the public gets angry.
"Mothers of children with peanut allergies are sending you heartbreaking letters," the game says after you raise the price past $400.
Public outrage tends to heighten when the media gets involved, such as when "Today Show" host Matt Lauer calls your situation "troubling."
If you attempt to lower the price too much to appease the public, you risk anger from your investors and get stern punishments such as "your private jet usage is being curtailed."
Raise the price not enough and "activist investors" oust you because of unprofitable drug prices.
But if the prices get too high, you have to resign after "constant thought pieces about how evil you are on 'Medium.'"
Throughout this high-wire act of keeping the price at an acceptable level for both sides, people who come to Mylan to get the EpiPen sometimes come away with the drug or just die.
The game ends when your salary gets high enough so you can cash out, and your company gets sold to infamous former pharmaceutical CEO Martin Shkreli, who raised the price of an anti-malarial drug Daraprim by 5,000 percent last year.
The game was made by GOP Arcade, which said on its website that it makes lightweight games "designed to make all the hoopla surrounding the election slightly more enjoyable." Other controversial games include "Thoughts and Prayers: the Game!" that asks you to stop mass shootings with your thoughts and prayers, a criticism of inaction over gun control.
Mylan has tried multiple times to appease anger over the high prices. It announced a cheaper version of EpiPen that will cost $300, half the list price of $600.
Mylan also recently announced a $300 discount card and said it will expand the public assistance programs for underinsured and uninsured.
The moves have done little to appease lawmakers who are probing for answers on how Mylan came to the $600 price tag. On Wednesday, a trio of senators asked the federal government how the price hike is affecting federal programs such as Medicare and Medicaid.